Connect Biopharma (CNTB) Reports Positive Long-Term Data fro

Connect Biopharma (CNTB) Reports Positive Long-Term Data from the Maintenance Period Through Week 48 of CN002 Phase 2 Icanbelimod Trial

Connect Biopharma (CNTB) Reports Positive Long-Term Data from the Maintenance Period Through Week 48 of CN002 Phase 2 Icanbelimod Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Brian Feagan , Zheng Wei , Tim Mccarthy , Shulich School Of Medicine Dentistry , Exchange Commission , University Of Western Ontario , Modulation Technology , Company Annual Report On Form , Biopharma Holdings , Biopharma Holdings Limited Nasdaq , Biopharma Holdings Limited , Maintenance Period , Data Highlights , Shulich School , Connect Biopharma , Immune Modulation Technology , Annual Report , Private Securities Litigation Reform Act ,